Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
08:20:02 EDT Thu 18 Apr 2024
Enter Symbol
or Name
USA
CA



T:VPH - VALEO PHARMA INC. J CLASS A - http://www.valeopharma.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
VPH - T  5.00.15·0.15511.00.15    0.53  0.13Apr 17Apr 0915 min RT 2¢
TSX - T5.00.15·0.15511.00.15    0.53  0.13Apr 1715 min

Recent Trades - All 0 today
Time ETExPriceChangeVolumeBuyerSellerMarkers
        
        
        
        
        
        
        
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-03-22 09:27C:VPH0.175News ReleaseValeo Pharma appoints Moghaddam as director
2024-03-15 09:16C:VPH0.195SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-03-15 09:10C:VPH0.195SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-03-14 17:38C:VPH0.195News ReleaseValeo Pharma loses $6.9-million in Q1 2024
2024-03-14 16:18C:VPH0.195SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-03-14 16:12C:VPH0.195SEDAR Interim MD & ASEDAR Interim MD & A
2024-03-14 16:12C:VPH0.195SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-03-07 09:25C:VPH0.195News ReleaseValeo Pharma to release Q1 2024 results March 14
2024-02-13 11:04C:VPH0.175News ReleaseValeo Pharma appoints Raich, Bisaillon as directors
2024-02-02 17:13C:VPH0.26News ReleaseValeo Pharma amends supply agreement with Novartis
2024-01-29 18:39C:VPH0.33SEDAR Annual Information FormSEDAR Annual Information Form
2024-01-29 18:39C:VPH0.33SEDAR Annual ReportSEDAR Annual Report
2024-01-29 18:39C:VPH0.33SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-01-29 18:39C:VPH0.33SEDAR MD & ASEDAR MD & A
2024-01-29 18:05C:VPH0.33News ReleaseValeo Pharma loses $27.8-million in fiscal 2023
2024-01-22 10:16C:VPH0.33News ReleaseValeo Pharma to release fiscal 2023 results Jan. 29
2023-11-20 10:24C:VPH0.18News ReleaseValeo Pharma to reduce $2M in operating costs
2023-11-07 13:14C:VPH0.145News ReleaseValeo Pharma appoints Lajoie as director
2023-09-27 10:11C:VPH0.235News ReleaseValeo enters $5M credit facility agreement with Accord
2023-09-13 19:57C:VPH0.285News ReleaseValeo Pharma loses $5.8-million in Q3 2023